|By Marketwired .||
|January 13, 2017 07:50 PM EST|
PALO ALTO, CA--(Marketwired - January 13, 2017) - Cooley advised Avidity Biosciences on its $16 million Series B financing. The round comprises $10 million in new capital and $6 million in convertible debt.
Takeda Pharmaceuticals, through its ventures group led the round, with new and existing investor participation from Alethea Capital, Alexandria Real Estate Equities, Brace Pharma, EcoR1 Capital, F-Prime Capital Partners, Moore Venture Partners and Tavistock Life Sciences.
Avidity is a privately held biotech company pioneering a new class of precision medicines -- Antibody-siRNA Conjugates (ASC) -- which combine the strengths of monoclonal antibodies and siRNA-based therapeutics. Avidity is working with partners to discover best-in-class drug candidates against important undrugged therapeutic targets.
The Cooley team advising Avidity included Josh Seidenfeld, Lesse Castleberry, Laura McDaniels and Kimberly Nguyen.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900 lawyers across 12 offices in the United States, China and Europe.
Apr. 25, 2017 06:15 AM EDT Reads: 754
Apr. 25, 2017 06:00 AM EDT Reads: 4,260
Apr. 25, 2017 05:00 AM EDT Reads: 142
Apr. 25, 2017 05:00 AM EDT Reads: 796
Apr. 25, 2017 05:00 AM EDT Reads: 3,345
Apr. 25, 2017 04:30 AM EDT Reads: 1,984
Apr. 25, 2017 04:30 AM EDT Reads: 2,986
Apr. 25, 2017 04:15 AM EDT Reads: 160
Apr. 25, 2017 04:15 AM EDT Reads: 4,990
Apr. 25, 2017 03:45 AM EDT Reads: 945
Apr. 25, 2017 03:45 AM EDT Reads: 796
Apr. 25, 2017 03:45 AM EDT Reads: 184
Apr. 25, 2017 03:30 AM EDT Reads: 177
Apr. 25, 2017 03:30 AM EDT Reads: 3,562
Keeping pace with advancements in software delivery processes and tooling is taxing even for the most proficient organizations. Point tools, platforms, open source and the increasing adoption of private and public cloud services requires strong engineering rigor – all in the face of developer demands to use the tools of choice. As Agile has settled in as a mainstream practice, now DevOps has emerged as the next wave to improve software delivery speed and output. To make DevOps work, organization...
Apr. 25, 2017 03:15 AM EDT Reads: 8,802